Health Minister Dr Harsh Vardhan inaugurates India’s first pneumococcal conjugate vaccine

▴ Health Minister Dr Harsh Vardhan inaugurates India’s first pneumococcal conjugate vaccine
Pneumosil is an example of India's capability in Research and Development and manufacturing high end sophisticated Vaccines

Health Minister Dr Harsh Vardhan yesterday inaugurated India’s first pneumococcal conjugate vaccine, PCV. The vaccine named Pneumosil has been developed by the Serum Institute of India Private Limited, SIIPL in collaboration with partners like the Bill and Melinda Gates Foundation.

Recognizing SIIPL as the world’s largest manufacturer of vaccines by number of doses and its contribution to India’s economy, Dr Harsh Vardhan remarked that Serum Institute’s Vaccines are used in 170 countries and every third child in the world is immunized with the manufacturer’s vaccine.

He reminded the audience that SIIPL developed and got license of first indigenous Pneumococcal Conjugate Vaccine from Government of India during COVID-19 pandemic lock-down in line with Prime Minister Narendra Modi’s vision of Atmanirbhar Bharat. He also mentioned about the extraordinary efforts of Ministry of Health and Family Welfare in this endeavour to make India self-reliant in PCV.

Speaking on the Prime Minister’s commitment of Atmanirbhar Bharat and his vision of Making in India for the World, Dr Harsh Vardhan noted that Pneumosil is an example of India's capability in Research and Development and manufacturing high end sophisticated Vaccines.

He said, it is matter of pride for our country for this historical milestone during COVID-19 Pandemic because till now we are fully dependent on Pneumococcal Conjugate Vaccine manufactured by foreign manufacturers which are available at very high prices. He said, Pneumonia is the single largest infectious cause of death among children under five years of age worldwide, accounting for nearly 10 lakhs deaths globally.

Tags : #DrHarshVardhan #SerumInstituteofIndiaPrivateLimited #BillandMelindaGatesFoundation #PMnarendraModi #AtmanirbharBharat #COVID-19Pandemic

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Surviving Against the Odds: Steven Spinale's Journey After an Ingrown Hair Turns DeadlyMarch 29, 2024
10 reasons why media research and Planning are essential in Healthcare marketingMarch 29, 2024
The Surprising Link Between Sleep and Age Perception: What You Need to KnowMarch 29, 2024
The Dark Side of Beauty: Kidney Damage from Hair Straightening TreatmentsMarch 29, 2024
The Dark Side of Beauty: Kidney Damage from Hair Straightening TreatmentsMarch 29, 2024
Avance Clinical at World Vaccine Congress to Share Latest Vaccine Clinical Trial News Including an HIV-1 StudyMarch 29, 2024
Sexual wellness superstore, Love Depot launches digital campaign to deliver every desireMarch 28, 2024
Recharge Your Life: Simple Ways to Boost Your Physical and Mental EnergyMarch 28, 2024
The Neurological Toll of Common Household Chemicals: Insights from Recent ResearchMarch 28, 2024
The Aging Puzzle: Decoding the Mechanisms of AgingMarch 28, 2024
The Double-Edged Sword of Kala-azar Treatment: Shedding Light on Eye ComplicationsMarch 28, 2024
FTCCI Launches Industry-Academia Connect to improve the employability of Engineering Graduates and address the growing demand for Talent in Emerging TechMarch 27, 2024
NTT and Olympus Begin World's First Joint Demonstration Experiment of Cloud Endoscopy SystemMarch 27, 2024
NTT and Olympus Begin World's First Joint Demonstration Experiment of Cloud Endoscopy SystemMarch 27, 2024
2nd Edition of IIFL JITO Ahimsa Run for peace & for non-violence to be held on 31st MarchMarch 27, 2024
Brij Hotels Announced 4 Million in Series A Funding March 27, 2024
Combatting Childhood Sedentariness: The Key to Preventing Premature Vascular DamageMarch 27, 2024
Crucial Findings: Unlocking Paths to Combat Ebola's DevastationMarch 27, 2024
Guarding Against Disease: The Crucial Role of Oral Hygiene in Preventive HealthcareMarch 27, 2024
Sanofi & Cipla announce exclusive distribution partnership to expand reach of CNS portfolio in IndiaMarch 26, 2024